Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06146257
Status:
RECRUITING
Last Update Posted:
2024-02-23
First Post:
2023-11-10
Brief Title:
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Sponsor:
GluBio Therapeutics Inc
Organization:
GluBio Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-08
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-10
First Submit QC Date:
November 21 2023
Study First Post Date:
2023-11-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-21
Last Update Post Date:
2024-02-23
Last Update Post Date Type:
ACTUAL